Education
About Us
Working with TipRanks
Follow Us
JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
Total Valuation
JB Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹276.42B. The enterprise value is ₹157.78B.
Market Cap₹276.42B
Enterprise Value₹157.78B
Share Statistics
JB Chemicals & Pharmaceuticals Ltd. has 156,058,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding156,058,930
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JB Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 38.83%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)38.83%
Return on Capital Employed (ROCE)0.53
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.92
Inventory Turnover2.49
Valuation Ratios
The current PE Ratio of JB Chemicals & Pharmaceuticals Ltd. is 37.30. JB Chemicals & Pharmaceuticals Ltd.’s PEG ratio is 0.37.
PE Ratio37.30
PS Ratio0.00
PB Ratio2.05
Price to Fair Value7.17
Price to FCF21.00
Price to Operating Cash Flow15.74
PEG Ratio0.37
Income Statement
In the last 12 months, JB Chemicals & Pharmaceuticals Ltd. had revenue of 39.18B and earned 6.60B in profits. Earnings per share was 42.45.
Revenue39.18B
Gross Profit26.01B
Operating Income19.14B
Pretax Income8.87B
Net Income6.60B
EBITDA10.32B
Earnings Per Share (EPS)42.45
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
JB Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ₹8.5, resulting in a dividend yield of 0.95%
Dividend Per Share₹8.5
Dividend Yield0.95%
Payout Ratio36.01%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change4.05%
50-Day Moving Average1.65K
200-Day Moving Average1.73K
Relative Strength Index (RSI)65.69
Average Volume (3m)3.41K
Important Dates
JB Chemicals & Pharmaceuticals Ltd. upcoming earnings date is Aug 7, 2025, TBA (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend DateFeb 07, 2025
Financial Position
JB Chemicals & Pharmaceuticals Ltd. as a current ratio of 3.04, with Debt / Equity ratio of 1.74%
Current Ratio3.04
Quick Ratio2.20
Debt to Market Cap<0.01
Net Debt to EBITDA-0.10
Interest Coverage Ratio163.16
Taxes
In the past 12 months, JB Chemicals & Pharmaceuticals Ltd. has paid 2.28B in taxes.
Income Tax2.28B
Effective Tax Rate0.26
Enterprise Valuation
JB Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 23.75, with an EV/FCF ratio of 30.45.
EV to Sales6.25
EV to EBITDA23.75
EV to Free Cash Flow30.45
EV to Operating Cash Flow27.15
Balance Sheet
JB Chemicals & Pharmaceuticals Ltd. has ₹4.47B in cash and marketable securities with ₹278.90M in debt, giving a net cash position of -₹4.19B billion.
Cash & Marketable Securities₹4.47B
Total Debt₹278.90M
Net Cash-₹4.19B
Net Cash Per Share-₹26.83
Tangible Book Value Per Share₹129.72
Margins
Gross margin is 61.41%, with operating margin of 48.85%, and net profit margin of 16.83%.
Gross Margin61.41%
Operating Margin48.85%
Pretax Margin22.65%
Net Profit Margin16.83%
EBITDA Margin26.34%
EBIT Margin21.97%
Analyst Forecast
The average price target for JB Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―